Pre-Pandemic Trends Re-emerge in Pediatric Pedestrian Injury
Academic Pediatrics · 2026-10 · 103443
DOI: 10.1016/j.acap.2026.103443 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academic Pediatrics, 2026-10. Verfasst von Cassandra Peitzman und 16 weiteren Autor:innen. Beteiligte Einrichtung: Brigham and Women's Hospital (Mass General Brigham), Harvard Medical School, Boston, MA. Electronic address: cpeitzman@mgb.org. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Heart Lung and Blood Institute.
Abstract (Originalsprache)
OBJECTIVE: To quantify changes in the rates and demographic distribution of pediatric pedestrian injuries before and after the COVID-19 pandemic. METHODS: We used interrupted time series analysis to characterize pre- and post-2020 trends in volume, age, race/ethnicity, day/night timing, and severity of pedestrian injuries among children aged ≤15 seen in academic pediatric emergency departments within the Pediatric Health Information System (2016-2023). RESULTS: A total of 19,958 visits for pedestrian injury were identified. Annual volumes fell from a mean of 2,743 (CI 95% = 2,499, 2,988) to 1,789 in 2020, or an estimated 897 fewer than expected (95% CI = 612, 1180), then increased by 259 visits/year (95% CI = 200, 317) to 2,570 by 2023. This pattern was primarily driven by school-aged adolescent children (aged 10-15), whose visit volumes fell from 1,331 in 2016-2019 to 765 in 2020, then rebounded to 1,334 by 2023. The proportion of non-White children fell from 73.4% in 2016-2019 to 66.8% in 2020, then increased by 2.2%/year through 2023 to 72.9%. Daytime presentations similarly fell from 73.7% to 69.6% in 2020, then rebounded to 72.5% by 2023. No pandemic-associated changes were seen in mean Child Opportunity Index or income. CONCLUSIONS: The COVID-19 pandemic was associated with large but temporary decreases in overall pediatric pedestrian trauma volumes and percent non-White patients, especially during the day and among school-aged children. These patterns suggest that routine daily traffic exposure may contribute differently to pedestrian risk across age groups and racial/ethnic categories with potential implications for targeted safety interventions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Brigham and Women's Hospital (Mass General Brigham), Harvard Medical School, Boston, MA. Electronic address: cpeitzman@mgb.org.
- Children's Hospital Association, Washington DC.
- Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL.
- Yale-New Haven Hospital, Yale University School of Medicine, New Haven, CT.
- Boston Children's Hospital, Harvard Medical School, Boston, MA.
- Children's National Hospital, George Washington University School of Medicine and Health Sciences, Washington, DC.
Förderung
- National Heart Lung and Blood Institute
Zitieren
APA
Peitzman, C., Hall, M., Alpern, E., Aronson, P., Geanacopoulos, A. T., Goyal, M. K., Gutman, C. K., Hall, J., Kemal, S., Neuman, M. I., Peltz, A., Rojas, C., Shanahan, K., Simon, H. K., Wells, J. M., Zamani, M., & Samuels-Kalow, M. (2026). Pre-Pandemic Trends Re-emerge in Pediatric Pedestrian Injury. Academic Pediatrics, 103443. https://doi.org/10.1016/j.acap.2026.103443
Vancouver
Peitzman C, Hall M, Alpern E, Aronson P, Geanacopoulos AT, Goyal MK, et al. Pre-Pandemic Trends Re-emerge in Pediatric Pedestrian Injury. Academic Pediatrics. 2026:103443. doi:10.1016/j.acap.2026.103443
BibTeX
@article{Peitzman2026,
author = {Peitzman, Cassandra and Hall, Matt and Alpern, Elizabeth and Aronson, Paul and Geanacopoulos, Alexandra T and Goyal, Monika K and Gutman, Colleen Kays and Hall, Jeanine and Kemal, Samaa and Neuman, Mark I and Peltz, Alon and Rojas, Christina and Shanahan, Kristen and Simon, Harold K and Wells, Jordee M and Zamani, Mark and Samuels-Kalow, Margaret},
title = {Pre-Pandemic Trends Re-emerge in Pediatric Pedestrian Injury},
journal = {Academic Pediatrics},
year = {2026},
pages = {103443},
doi = {10.1016/j.acap.2026.103443}
}
EUVIMED